Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Choudhury

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
European Urology|December 17, 2018
Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate CancerAnis A Hamid, Kathryn P Gray, Grace Shaw, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A Sensor-enabled Digital Trier Social Stress Test in an Enterprise ContextRahul D Gavas, Ramesh K Ramakrishnan, P Balamuralidhar, et al.
ESMO Open|January 23, 2025
Association between DNA damage repair alterations and outcomes to <sup>177</sup>Lu-PSMA-617 in advanced prostate cancerA Rami, N S Rashid, C Zhong, et al.
Phytochemical Analysis : PCA|February 8, 2017
Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silicoSubrata Das, Monjur A Laskar, Satyajit D Sarker, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2019
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern IndiaT K Banerjee, M Saha, E Ghosh, et al.
The Prostate|June 9, 2018
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancerAtish D Choudhury, Kathryn P Gray, Jeffrey G Supko, et al.
ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing ChallengesPraful Ravi, Bridget Whelpley, Emma Kelly, et al.
Journal of Environmental Management|April 1, 2018
Demonstration of acid and water recovery systems: Applicability and operational challenges in Indian metal finishing SMEsM Balakrishnan, R Batra, V S Batra, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
European Urology|December 17, 2018
Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate CancerAnis A Hamid, Kathryn P Gray, Grace Shaw, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A Sensor-enabled Digital Trier Social Stress Test in an Enterprise ContextRahul D Gavas, Ramesh K Ramakrishnan, P Balamuralidhar, et al.
ESMO Open|January 23, 2025
Association between DNA damage repair alterations and outcomes to <sup>177</sup>Lu-PSMA-617 in advanced prostate cancerA Rami, N S Rashid, C Zhong, et al.
Phytochemical Analysis : PCA|February 8, 2017
Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silicoSubrata Das, Monjur A Laskar, Satyajit D Sarker, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2019
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern IndiaT K Banerjee, M Saha, E Ghosh, et al.
The Prostate|June 9, 2018
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancerAtish D Choudhury, Kathryn P Gray, Jeffrey G Supko, et al.
ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing ChallengesPraful Ravi, Bridget Whelpley, Emma Kelly, et al.
Journal of Environmental Management|April 1, 2018
Demonstration of acid and water recovery systems: Applicability and operational challenges in Indian metal finishing SMEsM Balakrishnan, R Batra, V S Batra, et al.
Pageof 16